Rgcc

We focus our efforts on rgcc a range of cancer care options that go beyond traditional chemotherapy.

Circulating Tumor Cells CTCs are cells that have detached from the primary tumor and flow into the blood or lymphatic circulation creating a secondary tumor. Despite their rare population, these cells exhibit metastatic attributes and are related to cancer progression. The R. It enumerates only the progenitor cells that are relevant to potent relapse and recurrence of the disease. This test is a tailor-made test for specific type of malignancies such as breast cancer Oncotrail R.

Rgcc

Our range of tests and therapies is designed to discover, analyse and screen cancer cells at every step of the disease, and to provide vital information that can help clinicians to identify the best, and most effective, cancer treatments and therapies. We have tests that determine the cancer load, how much cancer is in the body and the risk of the cancer spreading or returning. The types of tests we offer fall into two categories: liquid biopsies and circulating tumour cell tests. Our liquid biopsy is a non-invasive blood test that requires no surgical intervention. It can detect circulating tumour cells and circulating free DNA in the blood. CTCs are cells that have detached from the original tumour and passed into the blood, the lymph system, or another part of the body, with the potential to create a second tumour. No, due to the blood-brain barrier, tumour cells cannot enter the bloodstream. This means that we cannot obtain and isolate any tumour cells from the blood sample. The test also contains information about the development of the tumour and its potential by identifying epigenetic tumour markers relevant for the therapy, which are crucial for the correct therapeutic approach. Online consultations will give you the opportunity to speak to any member of the RGCC Network at a time and place that is convenient to you. You will be able to choose from a shortlist of clinicians who best suit your needs. Your chosen clinician will be in touch to make the arrangements and choose the most convenient method. Skip to content Order a test. Need help?

Dedication to quality, rgcc, patient-centric approachand distinctive testing methodology, ensuring top-notch service. Information for patients We work with your healthcare provider to deliver a range of personalised tests so you can choose the best treatment together. Tackling your cancer together Discover the power of our non-invasive CTC blood rgcc, which provide real-time monitoring of your cancer rgcc using liquid biopsies, rgcc.

We are experts in developing and providing personalised cancer genetics tests for doctors and patients, and testing tumours for sensitivity and resistance to chemotherapy treatment and a range of natural substances. Working in the field of advanced medical genetics, our team of scientists and medical experts have developed a range of reliable tests so patients and clinicians can make informed decisions about healthcare. We make things better. Making sustainable choices is vital for the long-term health of our planet. Improving outcomes for cancer patients. Guiding treatment through genetic testing.

Our goal is simple yet powerful: to empower people facing cancer with tailored insights that can change the course of their journey. Our visionary leader, Dr. His passion and quest for innovation drive our relentless pursuit of groundbreaking advancements in personalized cancer care. RGCC was launched in by genetics pioneer Dr. Ioannis Papasotiriou with a view to developing personalized treatment options to treat cancer effectively. You can access our tests and protocols by connecting with one of our accredited providers.

Rgcc

This information can be used by your medical provider to advise on potential health risks a patient may face, and how these can be minimized. RGCC Metastat is an advanced test to detect specific blood-borne markers that can accurately determine whether a secondary cancerous tumor is likely to develop and its potential location. We analyze a sample to identify and measure circulating tumor cells CTCs. Metastat RGCC is suitable for all patients who have received a confirmed cancer diagnosis. The test can accurately detect the development of secondary cancers or tumors and improve personalized cancer treatments. RGCC Onconomics Plus provides information about the effect of specific anti-cancer drugs, targeted therapies and natural treatments on the cancer cells in an individual patient.

37 gbp to eur

RGCC We are experts in developing and providing personalised cancer genetics tests for doctors and patients, and testing tumours for sensitivity and resistance to chemotherapy treatment and a range of natural substances. Patient resources Our highly skilled and qualified team have created a service where patients can easily gain access to a wide range of pathology testing options. At RGCC, we go beyond identifying if you have cancer. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. The complexity of cancer makes personalization vital to cancer treatment. Practitioner login. Cells of the primary tumor that have the ability to metastasize will express specific genes and proteins according to the organ that will metastasize, and that is given by the genetic information. This means that every time you visit this website you will need to enable or disable cookies again. Find out more. Our liquid biopsy is a non-invasive blood test that requires no surgical intervention.

We focus our efforts on providing a range of cancer care options that go beyond traditional chemotherapy. The complexity of cancer makes personalization vital to cancer treatment. We offer personalized care solutions to improve your outcomes.

Your blood sample is sent to our state-of-the-art laboratories. Start your journey today. Metastat RGCC is an advanced test to detect specific blood-borne markers that can accurately determine whether a secondary cancerous tumour is likely to develop and its potential location. The R. Your chosen clinician will be in touch to make the arrangements and choose the most convenient method. Submit an enquiry. Frequently asked questions. Onco-D-Clare is a cancer screening test based on the interaction of molecular biology with artificial neural networks. Our highly skilled and qualified team have created a service where patients can easily gain access to a wide range of pathology testing options. Expanding cancer treatment beyond chemotherapy We focus our efforts on providing a range of cancer care options that go beyond traditional chemotherapy. Patient resources Our highly skilled and qualified team have created a service where patients can easily gain access to a wide range of pathology testing options. Need help? Onconomics RGCC Onconomics RGCC provides highly detailed and accurate information about how effective specific anti-cancer drugs and targeted therapies are in treating cancer.